SONOLATE-500 SONOBLATE-500

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2004-09-14 for SONOLATE-500 SONOBLATE-500 manufactured by Focus Surgery, Inc..

Event Text Entries

[27925872] Mr. (b)(6) underwent high intensity focused ultrasound treatment of the prostate for persistent prostate cancer on (b)(6) 2004. Three weeks postoperatively, he developed profuse diarrhea and was diagnosed with prostatic recto-urethral fistula. He will now require colostomy and repair. The hifu device, sonablate-500 is under ide study. The adverse event is an anticipated event. The ide study (b)(4) is now closed enrolling patients as it has completed allowable number for the study.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number5137152
MDR Report Key5137152
Date Received2004-09-14
Date of Report2004-09-09
Date of Event2004-08-21
Date Facility Aware2004-08-21
Report Date2004-09-09
Date Reported to FDA2004-09-14
Date Reported to Mfgr2004-09-14
Date Added to Maude2015-10-08
Event Key0
Report Source CodeUser Facility report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameSONOLATE-500
Generic NameHIGH INTENSITY FOCUSED ULTRASOUND
Product CodeNRZ
Date Received2004-09-14
Model NumberSONOBLATE-500
OperatorHEALTH PROFESSIONAL
Device Availability*
Device AgeNA
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerFOCUS SURGERY, INC.
Manufacturer AddressINDIANAPOLIS IN US


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2004-09-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.